About Spandan Khandelwal
Spandan's is a financial journalist and investment analyst focused on the stock market. With her ability to interpret financial data, she aims to help investors evaluate the fundamentals of a company before investing.
Spandan majored in accounting and finance in college and is currently pursuing the Cost and Management Accountant (CMA) program.
Recent Articles By Spandan Khandelwal
3 Popular Stocks Trading Well Below Their 2021 IPO Price
Last year marked a great year for IPOs, primarily due to a low-interest-rate environment, and investor optimism surrounding economic recovery. However, geopolitical tensions, market volatility, and other macroeconomic issues led to a decline in the prices of several initial public offerings in the first quarter of 2022. Popular stocks Toast (TOST), Nu Holdings (NU), and Robinhood Markets (HOOD), which made their market debut last year, are currently trading significantly below their IPO prices. So, let’s evaluate these names.
3 Stocks Under $2 That Will More Than Double in the Next 12 Months, According to Wall Street
Surging inflation, interest rate hikes, and geopolitical uncertainties have recently put the stock market under pressure. So, it could be wise to bet on low-priced stocks that possess solid rebound prospects. Wall Street Analysts expect low-priced stocks PaySign, Inc. (PAYS), Sorrento Therapeutics, Inc. (SRNE), and National CineMedia, Inc. (NCMI) to more than double in the next 12 months.
3 Stocks Warren Buffett Just Bought That Deserve a Place in Your Portfolio
The stock market has been under immense pressure since the beginning of the year due to several macroeconomic and geopolitical uncertainties. Amid the current turmoil, renowned investor Warren Buffett's top portfolio holdings may be appealing investments owing to their strong growth potential and ability to endure market headwinds. Recently bought Warren Buffett stocks Celanese Corporation (CE), McKesson Corporation (MCK), and HP Inc. (HPQ) could be solid additions to your portfolio.
Down More Than 45%: 2 Buy-Rated Stocks Snatch Up Now
Concerns over high inflation, the Fed's hawkish monetary policy, and the potential for the economy to slide into a recession have caused the market to suffer a significant correction of late. But the current downtrend could be a great opportunity to scoop up shares of quality companies LiveRamp Holdings (RAMP) and Herbalife Nutrition (HLF), which are down more than 45% in price. These stocks are rated Buy in our proprietary rating system.
5 High Growth Stocks to Buy Amid a Volatile Market
Concerns over aggressive interest rate hikes to fight the multi-decade high inflation and a looming recession have recently kept the stock market under pressure. However, growth stocks Taro Pharmaceutical (TARO), Superior Industries (SUP), Viavi Solutions (VIAV), CEVA (CEVA), and SMART Global Holdings (SGH) are well-positioned to rebound.
Microsoft vs. Adobe: Which Software Stock is a Better Buy?
Given the rising adoption of advanced technologies and rapid digitization, the software industry is poised to grow in the near term. Prominent software stocks Microsoft Corporation (MSFT) and Adobe Inc. (ADBE) look well-positioned to capitalize on the industry tailwinds. But which of these stocks is a better buy now? Read on to learn what we think.
3 Pharmaceutical Stocks That Look Like Huge Bargains
Increasing investments in R&D and rising expenditure on healthcare are expected to bolster the pharmaceutical sector's growth. Therefore, we think the stocks of fundamentally sound pharmaceutical companies Bristol-Myers Squibb (BMY), Bayer Aktiengesellschaft (BAYRY), and Catalyst Pharmaceuticals, Inc. (CPRX), which are currently trading at huge discounts to their peers, could be solid additions to one’s portfolio. Let’s take a closer look at these names.
4 Top-Rated Stocks Under $10 to Buy This Month
Though the major stock market indexes made a comeback yesterday following statements from the Biden administration hinting at the possibility of removing U.S tariffs on China, concerns over surging inflation and consequent monetary policy tightening are anticipated to keep the stock market under pressure in the near term. Therefore, we think it could be wise to bet on fundamentally sound low-priced stocks Assertio Holdings, Inc. (ASRT), Overseas Shipholding Group, Inc. (OSG), SunCoke Energy, Inc. (SXC), and Global Cord Blood Corporation (CO). These stocks are top-rated in our proprietary rating system.
2 Undervalued Chemical Stocks to Buy Now
Despite the intensified supply chain disruptions caused by the Ukraine-Russia war, the chemical industry delivered impressive financial results in the first quarter of 2022. Moreover, extensive demand for chemicals across various industries could help the sector rebound in the near term. Therefore, quality chemical stocks Huntsman Corporation (HUN) and AdvanSix Inc. (ASIX), which are currently trading at discounts to their peers, could be solid additions to your portfolio.